C.M. Reilly

409 total citations
8 papers, 271 citations indexed

About

C.M. Reilly is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C.M. Reilly has authored 8 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Neurology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C.M. Reilly's work include Neurogenetic and Muscular Disorders Research (2 papers), Inflammatory Bowel Disease (2 papers) and Amyotrophic Lateral Sclerosis Research (2 papers). C.M. Reilly is often cited by papers focused on Neurogenetic and Muscular Disorders Research (2 papers), Inflammatory Bowel Disease (2 papers) and Amyotrophic Lateral Sclerosis Research (2 papers). C.M. Reilly collaborates with scholars based in Australia, United Kingdom and Ireland. C.M. Reilly's co-authors include Christopher Burgess, Peter Lewindon, Richard Muir, Zubin Grover, Ammar Al‐Chalabi, Leonard H. van den Berg, Steve Vucic, Kevin Talbot, William Huynh and Matthew C. Kiernan and has published in prestigious journals such as Blood, Gastroenterology and CHEST Journal.

In The Last Decade

C.M. Reilly

6 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.M. Reilly Australia 4 157 87 67 58 42 8 271
John Howard United States 10 100 0.6× 53 0.6× 29 0.4× 77 1.3× 18 0.4× 26 277
Amina Gargouri Tunisia 10 138 0.9× 27 0.3× 32 0.5× 36 0.6× 14 0.3× 70 284
Anaita Hegde India 10 84 0.5× 36 0.4× 24 0.4× 58 1.0× 29 0.7× 32 240
Colleen F. Stevens United States 7 53 0.3× 160 1.8× 56 0.8× 166 2.9× 16 0.4× 11 337
Kenneth G. Kupke United States 12 157 1.0× 29 0.3× 114 1.7× 104 1.8× 30 0.7× 15 389
Kouki Makioka Japan 10 158 1.0× 34 0.4× 25 0.4× 98 1.7× 37 0.9× 34 296
Isabell Cordts Germany 11 96 0.6× 123 1.4× 19 0.3× 107 1.8× 9 0.2× 28 269
Acary Bulle Oliveira Brazil 8 110 0.7× 57 0.7× 25 0.4× 54 0.9× 5 0.1× 25 278
M. James United Kingdom 7 53 0.3× 38 0.4× 29 0.4× 115 2.0× 16 0.4× 24 239
Swati Aggarwal India 8 206 1.3× 126 1.4× 13 0.2× 76 1.3× 8 0.2× 17 329

Countries citing papers authored by C.M. Reilly

Since Specialization
Citations

This map shows the geographic impact of C.M. Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.M. Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.M. Reilly more than expected).

Fields of papers citing papers by C.M. Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.M. Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.M. Reilly. The network helps show where C.M. Reilly may publish in the future.

Co-authorship network of co-authors of C.M. Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of C.M. Reilly. A scholar is included among the top collaborators of C.M. Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.M. Reilly. C.M. Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Reilly, C.M., et al.. (2025). The use of oral antibiotic cocktail in medically refractory paediatric acute severe colitis: a case series. European Journal of Gastroenterology & Hepatology. 37(5). 594–599.
3.
Burgess, Christopher, et al.. (2021). 181 PAEDIATRIC PRIMARY SCLEROSING CHOLANGITIS-ULCERATIVE COLITIS.AUDIT OF 2 YEAR OUTCOME WITH ORAL VANCOMYCIN TREATMENT.. Gastroenterology. 160(6). S–44. 2 indexed citations
4.
Kiernan, Matthew C., Steve Vucic, Kevin Talbot, et al.. (2020). Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nature Reviews Neurology. 17(2). 104–118. 178 indexed citations
5.
Rodrigues, Miriam, et al.. (2018). Establishment and 12-month progress of the New Zealand Motor Neurone Disease Registry. Journal of Clinical Neuroscience. 60. 7–11. 5 indexed citations
6.
Grover, Zubin, Christopher Burgess, Richard Muir, C.M. Reilly, & Peter Lewindon. (2016). Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn’s disease. Journal of Crohn s and Colitis. 10(10). 1159–1164. 68 indexed citations
7.
Reilly, C.M., et al.. (2008). Androgens, Exercise Capacity, and Muscle Function in Cystic Fibrosis. CHEST Journal. 134(6). 1258–1264. 17 indexed citations
8.
Federico, Massimo, Martin J.S. Dyer, Marı́a Dolores Caballero, C.M. Reilly, & Eckhard Thiel. (2004). The MYOCAN Study. A Phase II Study of Cyclophosphamide, Oncovin, Myocet™, and Prednisone Plus Rituximab (R-COMP) in the Treatment of Elderly Patients with Diffuse Large B-Cell Non-Hodgkin Lymphoma (DLBCL).. Blood. 104(11). 4586–4586. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026